QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity

被引:10
作者
Garcia, Mariana L. [1 ]
de Oliveira, Andrew A. [1 ]
Bueno, Renata, V [1 ]
Nogueira, Victor H. R. [1 ]
de Souza, Guilherme E. [1 ]
Guido, Rafael V. C. [1 ]
机构
[1] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
malaria; N-myristoyltransferase; QSAR; EFFICIENT GENERATION; ELECTROSTATIC POTENTIALS; ANALYSIS COMSIA; ORBITAL METHODS; FIELD ANALYSIS; AM1-BCC MODEL; PREDICTION; DISCOVERY; 3D-QSAR; DESIGN;
D O I
10.1002/ddr.21646
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium and transmitted by Anopheles spp. mosquitos. Due to the emerging resistance to currently available drugs, great efforts must be invested in discovering new molecular targets and drugs. N-myristoyltransferase (NMT) is an essential enzyme to parasites and has been validated as a chemically tractable target for the discovery of new drug candidates against malaria. In this work, 2D and 3D quantitative structure-activity relationship (QSAR) studies were conducted on a series of benzothiophene derivatives as P. falciparum NMT (PfNMT) and human NMT (HsNMT) inhibitors to shed light on the molecular requirements for inhibitor affinity and selectivity. A combination of Quantitative Structure-activity Relationship (QSAR) methods, including the hologram quantitative structure-activity relationship (HQSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity index analysis (CoMSIA) models, were used, and the impacts of the molecular alignment strategies (maximum common substructure and flexible ligand alignment) and atomic partial charge methods (Gasteiger-Huckel, MMFF94, AM1-BCC, CHELPG, and Mulliken) on the quality and reliability of the models were assessed. The best models exhibited internal consistency and could reasonably predict the inhibitory activity against both PfNMT (HQSAR: q(2)/r(2)/r(pred)(2) = 0.83/0.98/0.81; CoMFA: q(2)/r(2)/r(pred)(2) = 0.78/0.97/0.86; CoMSIA: q(2)/r(2)/r(pred)(2) = 0.74/0.95/0.82) and HsNMT (HQSAR: q(2)/r(2)/r(pred)(2) = 0.79/0.93/0.74; CoMFA: q(2)/r(2)/r(pred)(2) = 0.82/0.98/0.60; CoMSIA: q(2)/r(2)/r(pred)(2) = 0.62/0.95/0.56). The results enabled the identification of the polar interactions (electrostatic and hydrogen-bonding properties) as the major molecular features that affected the inhibitory activity and selectivity. These findings should be useful for the design of PfNMT inhibitors with high affinities and selectivities as antimalarial lead candidates.
引用
收藏
页码:264 / 284
页数:21
相关论文
共 78 条
[1]   New Molecular Targets and Strategies for Antimalarial Discovery [J].
Aguiar, Anna Caroline ;
de Sousa, Lorena R. F. ;
Garcia, Celia R. S. ;
Oliva, Glaucius ;
Guido, Rafael V. C. .
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (23) :4380-4402
[2]  
[Anonymous], 2007, OECD Employment Outlook 2007, P55
[3]   Open-source discovery of chemical leads for next-generation chemoprotective antimalarials [J].
Antonova-Koch, Yevgeniya ;
Meister, Stephan ;
Abraham, Matthew ;
Luth, Madeline R. ;
Ottilie, Sabine ;
Lukens, Amanda K. ;
Sakata-Kato, Tomoyo ;
Vanaerschot, Manu ;
Owen, Edward ;
Rodriguez, Juan Carlos Jado ;
Maher, Steven P. ;
Calla, Jaeson ;
Plouffe, David ;
Zhong, Yang ;
Chen, Kaisheng ;
Chaumeau, Victor ;
Conway, Amy J. ;
McNamara, Case W. ;
Ibanez, Maureen ;
Gagaring, Kerstin ;
Neria Serrano, Fernando ;
Eribez, Korina ;
Taggard, Cullin McLean ;
Cheung, Andrea L. ;
Lincoln, Christie ;
Ambachew, Biniam ;
Rouillier, Melanie ;
Siegel, Dionicio ;
Nosten, Francois ;
Kyle, Dennis E. ;
Gamo, Francisco-Javier ;
Zhou, Yingyao ;
Llinas, Manuel ;
Fidock, David A. ;
Wirth, Dyann F. ;
Burrows, Jeremy ;
Campo, Brice ;
Winzeler, Elizabeth A. .
SCIENCE, 2018, 362 (6419)
[4]   Spread of Artemisinin Resistance in Plasmodium falciparum Malaria [J].
Ashley, E. A. ;
Dhorda, M. ;
Fairhurst, R. M. ;
Amaratunga, C. ;
Lim, P. ;
Suon, S. ;
Sreng, S. ;
Anderson, J. M. ;
Mao, S. ;
Sam, B. ;
Sopha, C. ;
Chuor, C. M. ;
Nguon, C. ;
Sovannaroth, S. ;
Pukrittayakamee, S. ;
Jittamala, P. ;
Chotivanich, K. ;
Chutasmit, K. ;
Suchatsoonthorn, C. ;
Runcharoen, R. ;
Hien, T. T. ;
Thuy-Nhien, N. T. ;
Thanh, N. V. ;
Phu, N. H. ;
Htut, Y. ;
Han, K-T. ;
Aye, K. H. ;
Mokuolu, O. A. ;
Olaosebikan, R. R. ;
Folaranmi, O. O. ;
Mayxay, M. ;
Khanthavong, M. ;
Hongvanthong, B. ;
Newton, P. N. ;
Onyamboko, M. A. ;
Fanello, C. I. ;
Tshefu, A. K. ;
Mishra, N. ;
Valecha, N. ;
Phyo, A. P. ;
Nosten, F. ;
Yi, P. ;
Tripura, R. ;
Borrmann, S. ;
Bashraheil, M. ;
Peshu, J. ;
Faiz, M. A. ;
Ghose, A. ;
Hossain, M. A. ;
Samad, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (05) :411-423
[5]   The Development Process for Discovery and Clinical Advancement of Modern Antimalarials [J].
Ashton, Trent D. ;
Devine, Shane M. ;
Mohrle, Jorg J. ;
Laleu, Benoit ;
Burrows, Jeremy N. ;
Charman, Susan A. ;
Creek, Darren J. ;
Sleebs, Brad E. .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (23) :10526-10562
[6]   Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis [J].
Baragana, Beatriz ;
Forte, Barbara ;
Choi, Ryan ;
Hewitt, Stephen Nakazawa ;
Bueren-Calabuig, Juan A. ;
Pisco, Joao Pedro ;
Peet, Caroline ;
Dranow, David M. ;
Robinson, David A. ;
Jansen, Chimed ;
Norcross, Neil R. ;
Vinayak, Sumiti ;
Anderson, Mark ;
Brooks, Carrie F. ;
Cooper, Caitlin A. ;
Damerow, Sebastian ;
Delves, Michael ;
Dowers, Karen ;
Duffy, James ;
Edwards, Thomas E. ;
Hallyburton, Irene ;
Horst, BenjaminG. ;
Hulverson, Matthew A. ;
Ferguson, Liam ;
Belen Jimenez-Diaz, Maria ;
Jumani, Rajiv S. ;
Lorimer, Donald D. ;
Love, Melissa S. ;
Maher, Steven ;
Matthews, Holly ;
McNamara, Casew. ;
Miller, Peter ;
O'Neill, Sandra ;
Ojo, Kayode K. ;
Osuna-Cabello, Maria ;
Pinto, Erika ;
Post, John ;
Riley, Jennifer ;
Rottmann, Matthias ;
Sanz, Laura M. ;
Scullion, Paul ;
Sharma, Arvind ;
Shepherd, Sharon M. ;
Shishikura, Yoko ;
Simeons, Frederick R. C. ;
Stebbins, Erin E. ;
Stojanovski, Laste ;
Straschil, Ursula ;
Tamaki, Fabio K. ;
Tamjar, Jevgenia .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (14) :7015-7020
[7]   A novel multiple-stage antimalarial agent that inhibits protein synthesis [J].
Baragana, Beatriz ;
Hallyburton, Irene ;
Lee, Marcus C. S. ;
Norcross, Neil R. ;
Grimaldi, Raffaella ;
Otto, Thomas D. ;
Proto, William R. ;
Blagborough, Andrew M. ;
Meister, Stephan ;
Wirjanata, Grennady ;
Ruecker, Andrea ;
Upton, Leanna M. ;
Abraham, Tara S. ;
Almeida, Mariana J. ;
Pradhan, Anupam ;
Porzelle, Achim ;
Santos Martinez, Maria ;
Bolscher, Judith M. ;
Woodland, Andrew ;
Norval, Suzanne ;
Zuccotto, Fabio ;
Thomas, John ;
Simeons, Frederick ;
Stojanovski, Laste ;
Osuna-Cabello, Maria ;
Brock, Paddy M. ;
Churcher, Tom S. ;
Sala, Katarzyna A. ;
Zakutansky, Sara E. ;
Belen Jimenez-Diaz, Maria ;
Maria Sanz, Laura ;
Riley, Jennifer ;
Basak, Rajshekhar ;
Campbell, Michael ;
Avery, Vicky M. ;
Sauerwein, Robert W. ;
Dechering, Koen J. ;
Noviyanti, Rintis ;
Campo, Brice ;
Frearson, Julie A. ;
Angulo-Barturen, Inigo ;
Ferrer-Bazaga, Santiago ;
Javier Gamo, Francisco ;
Wyatt, Paul G. ;
Leroy, Didier ;
Siegl, Peter ;
Delves, Michael J. ;
Kyle, Dennis E. ;
Wittlin, Sergio ;
Marfurt, Jutta .
NATURE, 2015, 522 (7556) :315-+
[8]   DETERMINING ATOM-CENTERED MONOPOLES FROM MOLECULAR ELECTROSTATIC POTENTIALS - THE NEED FOR HIGH SAMPLING DENSITY IN FORMAMIDE CONFORMATIONAL-ANALYSIS [J].
BRENEMAN, CM ;
WIBERG, KB .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (03) :361-373
[9]  
Brunschwig C, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00012-18, 10.1128/aac.00012-18]
[10]  
BURROWS JN, 2017, MALARIA J, V16